Establish Galactoside Derivatives Gene Vector Targeting ASGPR for Therapeutic Approach of Hepatocellular Carcinoma

Establish Galactoside Derivatives Gene Vector Targeting ASGPR for Therapeutic Approach of Hepatocellular Carcinoma

碩士 === 國立清華大學 === 生物醫學工程研究所 === 106

Bibliographic Details
Main Authors:	Huang, Kuan-Wei, 黃冠瑋
Other Authors:	Chen, Yunching
Format:	Others
Language:	en_US
Published:	2018
Online Access:	http://ndltd.ncl.edu.tw/handle/rm76jq

Similar Items

Expression of ASBT and ASGPR mediated receptors for oral liver-targeting preparations in a rat model of hepatic alveolar echinococcosis
by: GAO Ruixue
Published: (2021-04-01)

Identification of Potentially Therapeutic Target Genes of Hepatocellular Carcinoma
by: Chengzhang Li, et al.
Published: (2020-02-01)

Synthesis of Multivalent Galactoside Derivatives toward Biomedical Application for Lectins
by: Lai, Yu Tsung, et al.
Published: (2016)

Targeting PIN1 as a Therapeutic Approach for Hepatocellular Carcinoma
by: Chi-Wai Cheng, et al.
Published: (2020-01-01)

Developed simvastatin chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate for ASGPR-mediated targeted HCC delivery with enhanced oral bioavailability
by: Tarek M. Faris, et al.
Published: (2020-12-01)

Inhibition of hepatitis B virus and induction of hepatoma cell apoptosis by ASGPR-directed delivery of shRNAs.
by: Jingwei Ma, et al.
Published: (2012-01-01)

Synthesis of Multivalent Galactoside and GalNAc Derivatives toward Biomedical Application
by: Huang, Shao-Feng, et al.
Published: (2017)

Antibacterial activity of galactoside analogues of biocides
by: Al-Sagher, Mohamed Ramadan
Published: (1992)

Regulation of genes involved in polyhydroxybutyrate, pectin, and galactoside metabolism in Bacillus spp.
by: Jer-Sheng Lin, et al.
Published: (2006)

Malvidin-3-galactoside from blueberry suppresses the growth and metastasis potential of hepatocellular carcinoma cell Huh-7 by regulating apoptosis and metastases pathways
by: Jie Lin, et al.
Published: (2020-06-01)

Transcriptomically Revealed Oligo-Fucoidan Enhances the Immune System and Protects Hepatocytes via the ASGPR/STAT3/HNF4A Axis
by: Chun-Chia Cheng, et al.
Published: (2020-06-01)

Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma
by: Manali Dimri, et al.
Published: (2020-02-01)

Molecular Targets, Pathways, and Therapeutic Implications for Hepatocellular Carcinoma
by: Jun Gong, et al.
Published: (2020-07-01)

STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma
by: Carol Lee, et al.
Published: (2019-10-01)

Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma
by: Yasuo Tanaka, et al.
Published: (2018-10-01)

Immunochemical studies of mammalian beta-galactoside ?-binding lectins
by: Carding, S. R.
Published: (1985)

Energy coupling to β-galactoside transport in Escherichia coli
by: Ahmed, S.
Published: (1983)

Methyl-alpha-galactoside enhances the mitogenicity of the lectin jacalin
by: S. R. Dalmau, et al.
Published: (1992-06-01)

Self-assemblies behaviour of palm oil-based galactoside
by: Aripin, N.F.K, et al.
Published: (2018)

CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment
by: Yinjiang Zhang, et al.
Published: (2021-08-01)

Autophagy: A Potential Therapeutic Target of Polyphenols in Hepatocellular Carcinoma
by: Chandramohan Kiruthiga, et al.
Published: (2020-02-01)

EpCAM as a novel therapeutic target for hepatocellular carcinoma
by: Vasanthakumar S, et al.
Published: (2017-07-01)

MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target
by: Chao-Hung Hung, et al.
Published: (2014-01-01)

Microtubule-targeting agents in oncology and therapeutic potential in hepatocellular carcinoma
by: Loong HH, et al.
Published: (2014-04-01)

Exosomal microRNAs as Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma
by: Andrei Sorop, et al.
Published: (2021-05-01)

Establishment of a novel therapeutic vector targeting the trigeminal ganglion in rats
by: Xu K, et al.
Published: (2016-02-01)

β-Galactoside-mediated tissue organization during islet reconstitution
by: Sae Kamitori, et al.
Published: (2016-03-01)

Retracted: microRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target
by: BioMed Research International
Published: (2021-01-01)

Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives
by: Catia Giovannini, et al.
Published: (2016-12-01)

Characterization of CRKL as a therapeutic target in sorafenib resistant hepatocellular carcinoma
by: Chia-Fen Chang, et al.
Published: (2014)

Exosomal Non-Coding RNAs: Regulatory and Therapeutic Target of Hepatocellular Carcinoma
by: Haoming Xia, et al.
Published: (2021-03-01)

Validation of Bmi1 as a Therapeutic Target of Hepatocellular Carcinoma in Mice
by: Shibo Qi, et al.
Published: (2014-11-01)

SND1-Targeted Gene Therapy for Hepatocellular Carcinoma
by: Mckiver, Bryan D
Published: (2018)

Isolation of a ß-galactoside-binding lectin from cat liver
by: L. Franco-Fraguas, et al.
Published: (2003-04-01)

Snake venom galactoside-binding lectins: a structural and functional overview
by: Marco A. Sartim, et al.
Published: (2015-10-01)

Methyl 6-deoxy-6-iodo-&#945;-d-galactoside
by: Shivali A. Gulab, et al.
Published: (2010-07-01)

Methyl 6-azido-6-deoxy-&#945;-d-galactoside
by: Janice M. H. Cheng, et al.
Published: (2011-08-01)

Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers
by: Jishun Lu, et al.
Published: (2015-04-01)

B-galactoside transport and utilization in normal and filamentous forms of E. coli.
by: Singh, Akhand P.
Published: (1970)

Dickkopf-1 and Amphiregulin as Novel Biomarkers and Potential Therapeutic Targets in Hepatocellular Carcinoma
by: Abeer E. Awad, et al.
Published: (2019-07-01)